Featured Research

from universities, journals, and other organizations

Geriatric Patients Receive Significant Benefit From Cochlear Implantation

Date:
September 23, 2008
Source:
American Academy of Otolaryngology -- Head and Neck Surgery
Summary:
Despite previous inconclusive research, geriatric patients do experience significant quality of life improvement after receiving cochlear implants for hearing loss, says new research.

Despite previous inconclusive research, geriatric patients do experience significant quality of life improvement (QOL) after receiving cochlear implants for hearing loss, says new research presented at the 2008 American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in Chicago, IL.*

The benefits of cochlear implantation for hearing loss in adult and pediatric populations are well established. Cochlear implant outcomes continue to improve with the development of new implant technology and speech rehabilitation methods.

As individuals are living longer, the demand for cochlear implantation in the geriatric population has increased. Previous research had indicated that the geriatric population may not benefit from the surgery, and geriatric patients have been passed over for intervention.

Researchers surveyed groups of geriatric cochlear implant recipients and younger patients with a variety of different QOL and hearing ability tests. Despite the fact that the geriatric patients scored lower on QOL factors than younger patients, research determined that they still experience significant benefit from the cochlear implant. Researchers also determined that co-morbid conditions like heart disease did not lower QOL in geriatric recipients.

*Title: Performance and QOL after Geriatric Cochlear Implantation. Presenters: Alexandros Georgolios; Kelley Melissa Dodson, MD; Cristina Baldassari, MD; Patrick G. Maiberger, MD; Aristides Sismanis, MD. Date: September 22, 2008.


Story Source:

The above story is based on materials provided by American Academy of Otolaryngology -- Head and Neck Surgery. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Otolaryngology -- Head and Neck Surgery. "Geriatric Patients Receive Significant Benefit From Cochlear Implantation." ScienceDaily. ScienceDaily, 23 September 2008. <www.sciencedaily.com/releases/2008/09/080922122415.htm>.
American Academy of Otolaryngology -- Head and Neck Surgery. (2008, September 23). Geriatric Patients Receive Significant Benefit From Cochlear Implantation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/09/080922122415.htm
American Academy of Otolaryngology -- Head and Neck Surgery. "Geriatric Patients Receive Significant Benefit From Cochlear Implantation." ScienceDaily. www.sciencedaily.com/releases/2008/09/080922122415.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins